Heim M E
Fortschr Med. 1982 Mar 4;100(9):343-6.
Newer aspects of therapeutic potentials of cannabis and cannabinoids are reviewed. The major active constituent of cannabis sativa, delta-9-tetrahydrocannabinol and synthetic cannabinoids are evaluated in several clinical trials on their antiemetic efficacy in cancer chemotherapy induced vomiting. 80% of patients refractory to standard antiemetic treatment could be improved with the synthetic cannabinoid levonantradol. Other therapeutic effects, which are presently investigated in clinical trials are analgesia, antispasticity, anticonvulsion and the reduction of intraocular pressure in glaucoma. The future goal of cannabinoid research is the separation between specific pharmacologic activities and undesirable psychotropic effects.
本文综述了大麻和大麻素治疗潜力的最新研究进展。对大麻的主要活性成分Δ⁹-四氢大麻酚和合成大麻素在多项临床试验中治疗癌症化疗引起呕吐的止吐疗效进行了评估。80%对标准止吐治疗无效的患者使用合成大麻素左南曲朵后症状得到改善。目前正在临床试验中研究的其他治疗作用包括镇痛、抗痉挛、抗惊厥以及降低青光眼患者的眼压。大麻素研究的未来目标是分离特定药理活性和不良精神效应。